Magnetic resonance imaging (MRI) is the cornerstone for evaluating patients with brain
masses such as primary and metastatic tumors. Important challenges in effectively detecting …

The advent of immunotherapy using immune checkpoint inhibitors (ICIs) and targeted
therapy (TT) has dramatically improved the prognosis of various cancer types. However …

Differentiating treatment-induced necrosis from tumor recurrence is a central challenge in
neuro-oncology. These 2 very different outcomes after brain tumor treatment often appear …

Purpose This meta-analysis examined roles of several metabolites in differentiating
recurrent tumor from necrosis in patients with brain tumors using MR perfusion and …

We examine the role of dynamic susceptibility contrast (DSC) magnetic resonance imaging
(MRI) perfusion in differentiating pseudoprogression from progression in 20 consecutive …

Purpose To develop a classification model using texture features and support vector
machine in contrast‐enhanced T1‐weighted images to differentiate between brain …

Brain metastases are the most common intracranial tumors and occur in 20–40% of all
cancer patients. Lung cancer, breast cancer, and melanoma are the most frequent primary …

Introduction This systematic review aims to elucidate the diagnostic accuracy of radiological
examinations to distinguish between brain radiation necrosis (BRN) and tumor progression …

Current emerging MRI tools for radionecrosis and pseudoprogr... : Current Opinion in Oncology
Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis : Current …

Background High radiation doses of stereotactic radiosurgery (SRS) for brain metastases
(BM) can increase the likelihood of radiation necrosis (RN). Advanced MRI sequences can …